^
BIOMARKER:

ALK positive

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
ALK positive
Non Small Cell Lung Cancer
lorlatinib
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
alectinib
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
brigatinib
Sensitive
:
A1
ALK positive
Non-Hodgkin’s Lymphoma
crizotinib
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
crizotinib
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
ensartinib
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
bevacizumab + atezolizumab
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
ceritinib
Sensitive
:
A1
ALK positive
Non Small Cell Lung Cancer
atezolizumab
Sensitive
:
A1
ALK positive
Non-Hodgkin’s Lymphoma
alectinib
Sensitive
:
A2
ALK positive
Peripheral T-cell Lymphoma
crizotinib
Sensitive
:
A2
ALK positive
Peripheral T-cell Lymphoma
alectinib
Sensitive
:
A2
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
bevacizumab
Sensitive
:
B
ALK positive
Non-Hodgkin’s Lymphoma
brentuximab vedotin
Sensitive
:
B
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
atezolizumab
Sensitive
:
B
ALK positive
Lymphoma
crizotinib
Sensitive
:
B
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
crizotinib
Sensitive
:
B
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
ensartinib
Sensitive
:
C1
ALK positive
Lung Adenocarcinoma
lorlatinib
Sensitive
:
C1
ALK positive
Lung Non-Small Cell Squamous Cancer
brigatinib
Sensitive
:
C1
ALK positive
Neuroendocrine Tumor
alectinib
Sensitive
:
C1
ALK positive
Neuroblastoma
lorlatinib
Sensitive
:
C1
ALK positive
Lung Cancer
lorlatinib
Sensitive
:
C1
ALK positive
Non Small Cell Lung Cancer
TQ-B3139
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
AUY922
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
SAF-189
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
atezolizumab + alectinib
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
pembrolizumab
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
WX-0593
Sensitive
:
C2
ALK positive
Mesothelioma
APG-2449
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
APG-2449
Sensitive
:
C2
ALK positive
Neuroblastoma
crizotinib
Sensitive
:
C3